Registered entities
Protagonist Therapeutics, Inc
Reg. No. 1377121United States
Protagonist Therapeutics Inc.
Reg. No. 98-0505495Belgium
Social engagement
Social engagement: 9.6K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Canaan, Lilly Ventures, Johnson & Johnson Innovation – JJDC; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 50% |
| Private equity | 1 | 7% |
| Other / undisclosed | 6 | 43% |
Recent activity
3 Jun 2026
Event
Jefferies Global Healthcare Conference
1 Jun 2026
Event
2026 European Hematology Association Congress (EHA2026 Congress)
15 May 2026
Event
TIDES: Oligonucleotides and Peptide Therapeutics USA 2026